Under COVID-19 Outbreak, how the Antidiabetic Drug Industry will develop is also analyzed in detail in Chapter 1.7 of the report.

In Chapter 2.4, we analyzed industry trends in the context of COVID-19.

In Chapter 3.5, we analyzed the impact of COVID-19 on the product industry chain based on the upstream and downstream markets.

In Chapters 6 to 10 of the report, we analyze the impact of COVID-19 on various regions and major countries.

In chapter 13.5, the impact of COVID-19 on the future development of the industry is pointed out.

ALSO READ : http://www.marketwatch.com/story/global-wood-drying-kilns-market-si...

A holistic study of the market is made by considering a variety of factors, from demographics conditions and business cycles in a particular country to market-specific microeconomic impacts. The study found the shift in market paradigms in terms of regional competitive advantage and the competitive landscape of major players.

Key players in the global Antidiabetic Drug market covered in Chapter 4:

Novo Nordisk

Takeda

Pfizer

Biocon

Halozyme Therapeutics

Sanofi-Aventis

Bristol-Myers Squibb

Oramed

Boehringer Ingelheim

Tonghua Dongbao

Eli Lilly

Wockhardt

In Chapter 11 and 13.3, on the basis of types, the Antidiabetic Drug market from 2015 to 2026 is primarily split into:

Alpha-Glucosidase Inhibitors

Biguanides, Sulphonylureas

Glp-1 Agonist

ALSO READ : http://www.marketwatch.com/story/global-animal-free-soft-gelatin-ca...

Meglitinides

Dpp-4 Inhibitors

Sglt-2

Thiazolidinediones

Other

In Chapter 12 and 13.4, on the basis of applications, the Antidiabetic Drug market from 2015 to 2026 covers:

Type I Diabetes

Type II Diabetes

Other

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2015-2026) of the following regions are covered in Chapter 5, 6, 7, 8, 9, 10, 13:

North America (Covered in Chapter 6 and 13)

United States

Canada

Mexico

Europe (Covered in Chapter 7 and 13)

Germany

UK

France

Italy

Spain

ALSO READ : http://www.marketwatch.com/story/global-high-temperature-plastics-m...

Russia

Others

Asia-Pacific (Covered in Chapter 8 and 13)

China

Japan

South Korea

Australia

India

Southeast Asia

Others

Middle East and Africa (Covered in Chapter 9 and 13)

Saudi Arabia

UAE

Egypt

Nigeria

South Africa

Others

South America (Covered in Chapter 10 and 13)

Brazil

Argentina

Columbia

Chile

Others

Years considered for this report:

Historical Years: 2015-2019

Base Year: 2019

Estimated Year: 2020

Forecast Period: 2020-2026

ALSO READ : http://www.marketwatch.com/story/global-personal-budgeting-software...

Table of Contents

1 Report Overview

1.1 Study Scope

1.2 Key Market Segments

1.3 Regulatory Scenario by Region/Country

1.4 Market Investment Scenario Strategic

1.5 Market Analysis by Type

1.5.1 Global Antidiabetic Drug Market Share by Type (2020-2026)

1.5.2 Alpha-Glucosidase Inhibitors

1.5.3 Biguanides, Sulphonylureas

1.5.4 Glp-1 Agonist

1.5.5 Meglitinides

1.5.6 Dpp-4 Inhibitors

1.5.7 Sglt-2

1.5.8 Thiazolidinediones

1.5.9 Other

1.6 Market by Application

1.6.1 Global Antidiabetic Drug Market Share by Application (2020-2026)

1.6.2 Type I Diabetes

1.6.3 Type II Diabetes

1.6.4 Other

1.7 Antidiabetic Drug Industry Development Trends under COVID-19 Outbreak

1.7.1 Global COVID-19 Status Overview

1.7.2 Influence of COVID-19 Outbreak on Antidiabetic Drug Industry Development

2. Global Market Growth Trends

2.1 Industry Trends

2.1.1 SWOT Analysis

2.1.2 Porter’s Five Forces Analysis

2.2 Potential Market and Growth Potential Analysis

2.3 Industry News and Policies by Regions

2.3.1 Industry News

2.3.2 Industry Policies

2.4 Industry Trends Under COVID-19

3 Value Chain of Antidiabetic Drug Market

3.1 Value Chain Status

3.2 Antidiabetic Drug Manufacturing Cost Structure Analysis

3.2.1 Production Process Analysis

3.2.2 Manufacturing Cost Structure of Antidiabetic Drug

3.2.3 Labor Cost of Antidiabetic Drug

3.2.3.1 Labor Cost of Antidiabetic Drug Under COVID-19

3.3 Sales and Marketing Model Analysis

3.4 Downstream Major Customer Analysis (by Region)

3.5 Value Chain Status Under COVID-19

4 Players Profiles

4.1 Novo Nordisk

4.1.1 Novo Nordisk Basic Information

4.1.2 Antidiabetic Drug Product Profiles, Application and Specification

4.1.3 Novo Nordisk Antidiabetic Drug Market Performance (2015-2020)

4.1.4 Novo Nordisk Business Overview

4.2 Takeda

4.2.1 Takeda Basic Information

ALSO READ : http://www.marketwatch.com/story/global-ultra-high-definition-uhd4k...

4.2.2 Antidiabetic Drug Product Profiles, Application and Specification

4.2.3 Takeda Antidiabetic Drug Market Performance (2015-2020)

4.2.4 Takeda Business Overview

4.3 Pfizer

4.3.1 Pfizer Basic Information

4.3.2 Antidiabetic Drug Product Profiles, Application and Specification

4.3.3 Pfizer Antidiabetic Drug Market Performance (2015-2020)

4.3.4 Pfizer Business Overview

4.4 Biocon

4.4.1 Biocon Basic Information

4.4.2 Antidiabetic Drug Product Profiles, Application and Specification

4.4.3 Biocon Antidiabetic Drug Market Performance (2015-2020)

4.4.4 Biocon Business Overview

4.5 Halozyme Therapeutics

4.5.1 Halozyme Therapeutics Basic Information

4.5.2 Antidiabetic Drug Product Profiles, Application and Specification

4.5.3 Halozyme Therapeutics Antidiabetic Drug Market Performance (2015-2020)

4.5.4 Halozyme Therapeutics Business Overview

4.6 Sanofi-Aventis

ALSO READ :

4.6.1 Sanofi-Aventis Basic Information

4.6.2 Antidiabetic Drug Product Profiles, Application and Specification

4.6.3 Sanofi-Aventis Antidiabetic Drug Market Performance (2015-2020)

4.6.4 Sanofi-Aventis Business Overview

4.7 Bristol-Myers Squibb

4.7.1 Bristol-Myers Squibb Basic Information

4.7.2 Antidiabetic Drug Product Profiles, Application and Specification

4.7.3 Bristol-Myers Squibb Antidiabetic Drug Market Performance (2015-2020)

4.7.4 Bristol-Myers Squibb Business Overview

4.8 Oramed

4.8.1 Oramed Basic Information

4.8.2 Antidiabetic Drug Product Profiles, Application and Specification

4.8.3 Oramed Antidiabetic Drug Market Performance (2015-2020)

4.8.4 Oramed Business Overview

4.9 Boehringer Ingelheim

4.9.1 Boehringer Ingelheim Basic Information

4.9.2 Antidiabetic Drug Product Profiles, Application and Specification

4.9.3 Boehringer Ingelheim Antidiabetic Drug Market Performance (2015-2020)

4.9.4 Boehringer Ingelheim Business Overview

4.10 Tonghua Dongbao

4.10.1 Tonghua Dongbao Basic Information

4.10.2 Antidiabetic Drug Product Profiles, Application and Specification

4.10.3 Tonghua Dongbao Antidiabetic Drug Market Performance (2015-2020)

…continued

CONTACT DETAILS :

[email protected]

+44 203 500 2763

+1 62 825 80070

971 0503084105